Good morning everyone, let me offer you an entirely

New Post Public Reply Private Reply Replies (1) Message Board
Zolis_onkel
415
Good morning everyone,

let me offer you an entirely different perspective on the current situation.
Before Joe has taken over, I had already lost all of my hopes that something good would still come from this investment.
Then the PR was published which let us shareholders know that a new management team was installed, and a first CC was held (in which, BTW, I already brought up the idea to spin out AE!!) and I get super excited and immediately after the 1000:1 RS loaded up more shares. This was in January of 2017, and after that no PR was published for 10 months or so, until November (maybe late October) of that year. I can't remember the exact dates and times, but I do remember that it was such a long time that I had lost all hopes again. But only to be positively surprised by the announcements that followed and the skyrocketing share price.

That much as a reminder. Now where are we at right now? We all complained about all the PRs without real substance and the sloppy ways to make predictions of events and time frames (the infamous "coming days" and "soon" etc.) that had us all excited only to be disappointed just a little while later. So let's be honest, what good have these PRs really done us? Nothing much, right?
Now that these types of PRs have been discontinued we are also complaining, but let's remind ourselves to the beginning of Joe's time in office. He said "hello, here I am, I am your new CEO" and then basically disappeared behind his office doors for many months, only to come back out with a big bang, a bang that immediately caused the pps to shoot up.

Anybody, who thinks he has given up, is, in my view, very much mistaken, but he rather had learned his lessons that only "did news" (such ss a signed contract, payments made, FDA approval received, etc.) really mean anything, and he skipped the "water level announcements", gets stuff done and once facts are made, he will announce them.
He has at least once already been successful with this exact strategy and I hope that he has returned back to exactly that again.
So let's be patient and wait for the next bang news to be presented to us. He has at least once surprised me with a big announcement that i was not at all counting on anymore and I am sure that he will be able to do exactly that again.

So let's put a check mark behind this year of missed opportunities, which could have been a breakthrough year, but for several reasons (not all of them being Joe's fault, but the SEC or the pandemic held up every progress, and in part BARDA /Operation Warp Speed is to blame for - in my view - not really doing their job properly by not spreading the available funding as widely as possible into as many different vaccine technologies as possible) it has not turned out that way. And remain curious to see what good is in the making behind closed doors, that will turn this company around another time. I am sure that Joe and his management team has laid out a plan and will inform us as soon as humanly possible about any real progress they have been able to make.

To a great 2021, in particular in regards to our GNBT/NGIO investment. Until then have a merry Christmas everyone.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 14

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

Woodward, Inc. Plans Earnings Release for Q3 2025 Conference

Updated Category News Views 159

Woodward, Inc. Announces Upcoming Earnings Release and Conference Call In the fast-evolving landscape of industrial solutions, Woodward, Inc. (NASDAQ: WWD) is setting the stage for its fiscal 2025 third quarter financial results announcement. The report is expected to be released on a strategic timeline, with the company aiming to share its insights around 4:00 p.m. ET on...

Continue Reading
BlackRock's Insight: Fed Rate Cuts May Surprise Markets

Updated Category News Views 186

Insights from BlackRock on Interest Rate Cuts Recently, experts at BlackRock have voiced concerns about the expected U.S. interest rate cuts. They believe that these cuts are unlikely to reach the depths that the market currently anticipates, largely because of the strong economy and ongoing inflation pressures. The Federal Reserve is on the brink of possibly implementing...

Continue Reading
Investors Could Lead Class Action Against ICON plc Securities

Updated Category News Views 115

Investors Have a Unique Opportunity with ICON plc The chance for investors to take active roles in legal actions against companies has amplified in recent years, particularly in the case of ICON plc (NASDAQ: ICLR). The demand for justice and accountability has fostered engagement among shareholders, especially those who have experienced losses due to allegedly misleading...

Continue Reading
League One Volleyball Secures Major Funding for Future Growth

Updated Category News Views 597

League One Volleyball Raises $100 Million in New Funding League One Volleyball (LOVB), a leading leader in U.S. volleyball, has achieved a significant milestone by securing $100 million in new funding. This investment is vital for supporting its junior clubs and the anticipated launch of its professional league. The funding round, spearheaded by Atwater Capital, also sees...

Continue Reading
On Time Trucking Celebrates ISO 9001 Certification Success

Updated Category News Views 145

On Time Trucking Achieves ISO 9001:2015 Certification On Time Trucking has recently reached a significant milestone by achieving the ISO 9001:2015 certification, demonstrating its commitment to quality management systems. This accomplishment follows a meticulous assessment and audit of its operational processes, affirming the company's dedication to excellence. Founded...

Continue Reading